RadioSyn
RadioSyn is designing and manufacturing a miniaturized automated radiopharmaceutical synthesis platform. We deliver a shielded, state-of-the-art synthesizer that eliminates traditional production barriers and complexity. Our automated synthesis technology platform addresses critical limitations in conventional diagnostic and therapeutic workflows by standardizing and streamlining radioimmunoconjugate and radiopharmaceutical manufacturing.
Our Platform
Our platform uses disposable microfluidic chips that perform end-to-end chemical and radiochemical reactions. The Radiosyn platform offers reproducible, high-quality radiopharmaceutical production across research and clinical settings, requiring minimal specialized radiochemistry expertise. The device offers cost-effective, on-demand delivery of radiopharmaceuticals, making it ideal for meeting the growing demand for personalized and precision medicine. Our mission is to accelerate scientific discovery and clinical use of radiopharmaceuticals by making their production more accessible, standardized, and scalable.
Our Team
Dr. Sam Sadeghi
CEO, Co-founder
Radiochemistry expert focused on business development and market positioning
Xueyi Wang
CSO, Co-founder
Radiochemistry Lead
Matthew McLennan
Automation Engineer
Dr. Ravi Selvaganapathy
CTO, Co-founder
Biomedical engineering expert focused on project management and business development
Shayan Jahangirifard
COO, Co-founder
Engineering Lead
Clara Jonkman
Microfluidic Engineer
We are Hiring!
RadioSyn is currently seeking a full time Microfluidic Engineer with strong expertise in microfabrication and microelectromechanical systems (MEMS) assembly. A detailed list of responsibilities and necessary qualifications can be found on our LinkedIn posting. Please send your resume, transcripts and a short cover letter highlighting relevant experience and projects to shayan@radiosyn.com.
Our Partners
